Literature DB >> 18550055

Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspective.

John E Nestler.   

Abstract

This editorial discusses the recent European Society for Human Reproduction and Embryology/American Society for Reproductive Medicine recommendations on the treatment of infertility in polycystic ovarian syndrome. Evidence is provided for the use of metformin in selected patients.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18550055      PMCID： PMC2495076          DOI： 10.1016/j.fertnstert.2008.04.073

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  18 in total

1.  Clinical and laboratory predictors of clomiphene response.

Authors:  R A Lobo; M Gysler; C M March; U Goebelsmann; D R Mishell
Journal:  Fertil Steril       Date:  1982-02       Impact factor: 7.329

2.  Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses.

Authors:  Lyndal R Harborne; Naveed Sattar; Jane E Norman; Richard Fleming
Journal:  J Clin Endocrinol Metab       Date:  2005-05-10       Impact factor: 5.958

3.  Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome.

Authors:  Stefano Palomba; Francesco Orio; Angela Falbo; Francesco Manguso; Tiziana Russo; Teresa Cascella; Achille Tolino; Enrico Carmina; Annamaria Colao; Fulvio Zullo
Journal:  J Clin Endocrinol Metab       Date:  2005-04-19       Impact factor: 5.958

4.  Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial.

Authors:  Etelka Moll; Patrick M M Bossuyt; Johanna C Korevaar; Cornelis B Lambalk; Fulco van der Veen
Journal:  BMJ       Date:  2006-06-12

5.  Effects of short-term and long-term metformin treatment on menstrual cyclicity in women with polycystic ovary syndrome.

Authors:  Paulina A Essah; Teimuraz Apridonidze; Maria J Iuorno; John E Nestler
Journal:  Fertil Steril       Date:  2006-05-23       Impact factor: 7.329

6.  Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

Authors:  R Pasquali; A Gambineri; D Biscotti; V Vicennati; L Gagliardi; D Colitta; S Fiorini; G E Cognigni; M Filicori; A M Morselli-Labate
Journal:  J Clin Endocrinol Metab       Date:  2000-08       Impact factor: 5.958

7.  Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.

Authors:  Jean-Patrice Baillargeon; Daniela J Jakubowicz; Maria J Iuorno; Salomon Jakubowicz; John E Nestler
Journal:  Fertil Steril       Date:  2004-10       Impact factor: 7.329

8.  Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome.

Authors:  Richard S Legro; Huiman X Barnhart; William D Schlaff; Bruce R Carr; Michael P Diamond; Sandra A Carson; Michael P Steinkampf; Christos Coutifaris; Peter G McGovern; Nicholas A Cataldo; Gabriella G Gosman; John E Nestler; Linda C Giudice; Phyllis C Leppert; Evan R Myers
Journal:  N Engl J Med       Date:  2007-02-08       Impact factor: 91.245

Review 9.  Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome--a reappraisal.

Authors:  Andrea Dunaif
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-03-25

10.  Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome.

Authors:  J E Nestler; D J Jakubowicz; W S Evans; R Pasquali
Journal:  N Engl J Med       Date:  1998-06-25       Impact factor: 91.245
View more
  15 in total

Review 1.  Fertility treatment in women with polycystic ovary syndrome: a decision analysis of different oral ovulation induction agents.

Authors:  Emily S Jungheim; Anthony O Odibo
Journal:  Fertil Steril       Date:  2010-05-07       Impact factor: 7.329

2.  How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology.

Authors:  P Moghetti; E Carmina; V De Leo; A Lanzone; F Orio; R Pasquali; V Toscano
Journal:  J Endocrinol Invest       Date:  2015-04-03       Impact factor: 4.256

Review 3.  Cardiometabolic aspects of the polycystic ovary syndrome.

Authors:  Harpal S Randeva; Bee K Tan; Martin O Weickert; Konstantinos Lois; John E Nestler; Naveed Sattar; Hendrik Lehnert
Journal:  Endocr Rev       Date:  2012-07-24       Impact factor: 19.871

Review 4.  Metformin use in women with polycystic ovary syndrome.

Authors:  Neil P Johnson
Journal:  Ann Transl Med       Date:  2014-06

Review 5.  Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.

Authors:  Mark O Goodarzi; Daniel A Dumesic; Gregorio Chazenbalk; Ricardo Azziz
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

6.  Metformin in women with PCOS, pros.

Authors:  Renato Pasquali; Pasquali Renato
Journal:  Endocrine       Date:  2014-06-10       Impact factor: 3.633

Review 7.  Contemporary approaches to the management of polycystic ovary syndrome.

Authors:  Renato Pasquali
Journal:  Ther Adv Endocrinol Metab       Date:  2018-02-07       Impact factor: 3.565

8.  The role of anti-Mullerian hormone and inhibin B in the assessment of metformin therapy in women with polycystic ovarian syndrome.

Authors:  Basil O Saleh; Wasan F Ibraheem; Nada S Ameen
Journal:  Saudi Med J       Date:  2015-05       Impact factor: 1.484

9.  Anti-Műllerian hormone--a prognostic marker for metformin therapy efficiency in the treatment of women with infertility and polycystic ovary syndrome.

Authors:  M Neagu; C Cristescu
Journal:  J Med Life       Date:  2012-12-25

10.  Sulfonylureas and their use in clinical practice.

Authors:  Daniele Sola; Luca Rossi; Gian Piero Carnevale Schianca; Pamela Maffioli; Marcello Bigliocca; Roberto Mella; Francesca Corlianò; Gian Paolo Fra; Ettore Bartoli; Giuseppe Derosa
Journal:  Arch Med Sci       Date:  2015-08-11       Impact factor: 3.318
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.